Basic Information

Reference Number

00002141303

Issuing Organization

University of British Columbia

Solicitation Type

NOI - Notice of Intent (Informal)

Solicitation Number

2019010444

Title

Clinical Research Study Project

Source ID

SCRIBE

Details

Location

British Columbia

Purchase Type

Not Stated

Dates

Publication

2020/04/20 01:16:00 PM EDT

Closing Date

2020/04/24 05:00:00 PM EDT

Contact Information

Hassan, Mohammed

mohammed.hassan@ubc.ca

Description

NOTICE OF INTENT (NOI) CLINICAL MONITORING RESEARCH STUDY. 2019010444

This is to inform you that The University of British Columbia (" UBC") intends to enter in a purchase agreement for Clinical Research Study with Emmes.

Vendor will provide clinical site monitoring for the study entitled Clinical Phase II/III Trial of Ustekinumab to treat Type 2 Diabetes (UST1D2).

Period of performance: 15 May 2020 - 15 May 2023 (tentative)

Clinical Sites: 2 in Canada (additional sites will incur additional costs)

Services Required:
· Clinical Operations Oversight and Clinical Site Monitoring
· Biostatistics and statistical programming
· Data Monitoring Committee administration
· Clinic payments, site contract management or per-patient costs
· Data Collection and Management
· Trial Master File support
· Safety Management or Pharmacovigilance Services

Note: Proponents cannot submit their Statement of Capability if they fail to confirm their Intent to Bid by the stated due date.

Disclaimer All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on bcbid.gov.bc.ca. MERX asks that you refer to bcbid.gov.bc.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.